392 related articles for article (PubMed ID: 18647985)
1. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics.
Havlir DV; Getahun H; Sanne I; Nunn P
JAMA; 2008 Jul; 300(4):423-30. PubMed ID: 18647985
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743
[TBL] [Abstract][Full Text] [Related]
3. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
Habib AG
Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
[TBL] [Abstract][Full Text] [Related]
4. Community-based multi-disease prevention campaigns for controlling human immunodeficiency virus-associated tuberculosis.
Suthar AB; Klinkenberg E; Ramsay A; Garg N; Bennett R; Towle M; Sitienei J; Smyth C; Daniels C; Baggaley R; Gunneberg C; Williams B; Getahun H; van Gorkom J; Granich RM
Int J Tuberc Lung Dis; 2012 Apr; 16(4):430-6. PubMed ID: 22640510
[TBL] [Abstract][Full Text] [Related]
5. New vaccines for the prevention of tuberculosis in human immunodeficiency virus infection.
von Reyn CF; Bakari M; Arbeit RD; Lahey T; Ramadhani A; Egwaga S
Int J Tuberc Lung Dis; 2012 Jun; 16(6):718-23. PubMed ID: 22507085
[TBL] [Abstract][Full Text] [Related]
6. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.
Frigati LJ; Kranzer K; Cotton MF; Schaaf HS; Lombard CJ; Zar HJ
Thorax; 2011 Jun; 66(6):496-501. PubMed ID: 21460373
[TBL] [Abstract][Full Text] [Related]
7. Review of policy and status of implementation of collaborative HIV-TB activities in 23 high-burden countries.
Gupta S; Granich R; Date A; Lepere P; Hersh B; Gouws E; Samb B
Int J Tuberc Lung Dis; 2014 Oct; 18(10):1149-58. PubMed ID: 25216827
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies.
Maher D; Harries A; Getahun H
Trop Med Int Health; 2005 Aug; 10(8):734-42. PubMed ID: 16045459
[TBL] [Abstract][Full Text] [Related]
9. Role of the US President's Emergency Plan for AIDS Relief in responding to tuberculosis and HIV coinfection.
Coggin WL; Ryan CA; Holmes CB
Clin Infect Dis; 2010 May; 50 Suppl 3():S255-9. PubMed ID: 20397956
[TBL] [Abstract][Full Text] [Related]
10. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
[TBL] [Abstract][Full Text] [Related]
11. TB and HIV: joint problems, joint solutions?
Elzinga G; Nunn P
Bull World Health Organ; 2002; 80(6):469-70. PubMed ID: 12132004
[No Abstract] [Full Text] [Related]
12. Missed opportunities for prevention of tuberculosis among persons with HIV infection--selected locations, United States, 1996-1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Aug; 49(30):685-7. PubMed ID: 10947056
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of tuberculosis and HIV: recent advances in understanding and responses.
Martinson NA; Hoffmann CJ; Chaisson RE
Proc Am Thorac Soc; 2011 Jun; 8(3):288-93. PubMed ID: 21653530
[TBL] [Abstract][Full Text] [Related]
14. Prevention of tuberculosis in people living with HIV.
Granich R; Akolo C; Gunneberg C; Getahun H; Williams P; Williams B
Clin Infect Dis; 2010 May; 50 Suppl 3():S215-22. PubMed ID: 20397951
[TBL] [Abstract][Full Text] [Related]
15. [Control of tuberculosis in relation to the HIV/AIDS epidemic. Work Group at the Secretariat of the National Plan on AIDS].
Rev Esp Salud Publica; 1999; 73(5):533-47. PubMed ID: 10650745
[TBL] [Abstract][Full Text] [Related]
16. Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned.
Howard AA; El-Sadr WM
Clin Infect Dis; 2010 May; 50 Suppl 3():S238-44. PubMed ID: 20397954
[TBL] [Abstract][Full Text] [Related]
17. Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations.
Cohen T; Lipsitch M; Walensky RP; Murray M
Proc Natl Acad Sci U S A; 2006 May; 103(18):7042-7. PubMed ID: 16632605
[TBL] [Abstract][Full Text] [Related]
18. Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues.
Aït-Khaled N; Alarcon E; Bissell K; Boillot F; Caminero JA; Chiang CY; Clevenbergh P; Dlodlo R; Enarson DA; Enarson P; Ferroussier O; Fujiwara PI; Harries AD; Heldal E; Hinderaker SG; Kim SJ; Lienhardt C; Rieder HL; Rusen ID; Trébucq A; Van Deun A; Wilson N
Int J Tuberc Lung Dis; 2009 Aug; 13(8):927-35. PubMed ID: 19723371
[TBL] [Abstract][Full Text] [Related]
19. The whole is greater than the sum of the parts: recognising missed opportunities for an optimal response to the rapidly maturing TB-HIV co-epidemic in South Africa.
Perumal R; Padayatchi N; Stiefvater E
BMC Public Health; 2009 Jul; 9():243. PubMed ID: 19607697
[TBL] [Abstract][Full Text] [Related]
20. HIV-associated tuberculosis: diagnostic and treatment challenges.
El-Sadr WM; Tsiouris SJ
Semin Respir Crit Care Med; 2008 Oct; 29(5):525-31. PubMed ID: 18810685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
